USD 254.94
(-3.24%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 220.9 Million USD | -1.3% |
2022 | 223.82 Million USD | 36.84% |
2021 | 163.56 Million USD | 129.57% |
2020 | 71.24 Million USD | -3.7% |
2019 | 73.99 Million USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | -100.0% |
2013 | 6 Million USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 214.71 Million USD | 0.0% |
2024 Q3 | 212.2 Million USD | 0.0% |
2024 Q1 | 217.63 Million USD | 0.0% |
2023 Q4 | 220.9 Million USD | 2.32% |
2023 Q2 | 218.57 Million USD | -1.21% |
2023 Q3 | 215.89 Million USD | -1.23% |
2023 Q1 | 221.26 Million USD | -1.14% |
2023 FY | 220.9 Million USD | -1.3% |
2022 Q2 | 208.8 Million USD | 0.12% |
2022 FY | 223.82 Million USD | 36.84% |
2022 Q3 | 206.22 Million USD | -1.24% |
2022 Q4 | 223.82 Million USD | 8.53% |
2022 Q1 | 208.56 Million USD | 27.51% |
2021 Q2 | 121.13 Million USD | 71.76% |
2021 Q1 | 70.52 Million USD | -1.02% |
2021 FY | 163.56 Million USD | 129.57% |
2021 Q3 | 164.94 Million USD | 36.17% |
2021 Q4 | 163.56 Million USD | -0.83% |
2020 Q4 | 71.24 Million USD | -1.57% |
2020 Q3 | 72.38 Million USD | 0.36% |
2020 FY | 71.24 Million USD | -3.7% |
2020 Q2 | 72.12 Million USD | -1.06% |
2020 Q1 | 72.89 Million USD | -1.47% |
2019 Q1 | 46.07 Million USD | 0.0% |
2019 Q4 | 73.99 Million USD | 62.97% |
2019 FY | 73.99 Million USD | 0.0% |
2019 Q2 | 46.14 Million USD | 0.16% |
2019 Q3 | 45.4 Million USD | -1.62% |
2018 FY | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 FY | - USD | -100.0% |
2013 FY | 6 Million USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Abbott Laboratories | 13.59 Billion USD | 98.376% |
Allurion Technologies Inc. | 2.3 Million USD | -9479.748% |
Artivion, Inc. | 305.53 Million USD | 27.697% |
Avanos Medical, Inc. | 159.4 Million USD | -38.588% |
Butterfly Network, Inc. | 22.83 Million USD | -867.414% |
Butterfly Network, Inc. | 22.83 Million USD | -867.414% |
Bio-Rad Laboratories, Inc. | 1.18 Billion USD | 81.428% |
Boston Scientific Corporation | 8.96 Billion USD | 97.535% |
CONMED Corporation | 971.48 Million USD | 77.261% |
Edwards Lifesciences Corporation | 670 Million USD | 67.029% |
Paragon 28, Inc. | 109.79 Million USD | -101.194% |
Glaukos Corporation | 383.73 Million USD | 42.432% |
Globus Medical, Inc. | 417.4 Million USD | 47.075% |
Inspire Medical Systems, Inc. | 24.84 Million USD | -789.113% |
Integer Holdings Corporation | 959.92 Million USD | 76.987% |
Medtronic plc | 23.87 Billion USD | 99.075% |
Myomo, Inc. | 115.16 Thousand USD | -191727.892% |
Nevro Corp. | 211.47 Million USD | -4.463% |
Owlet, Inc. | 22 Thousand USD | -1004031.818% |
Vicarious Surgical Inc. | 13.78 Million USD | -1502.532% |
Smith & Nephew plc | 2.17 Billion USD | 89.843% |
Sonendo, Inc. | 14.03 Million USD | -1473.986% |
STERIS plc | 3.12 Billion USD | 92.92% |
Stryker Corporation | 10.9 Billion USD | 97.973% |
Vapotherm, Inc. | 109.97 Million USD | -100.867% |
Zimmer Biomet Holdings, Inc. | 4.86 Billion USD | 95.462% |